Philip M. Tedeschi

1.1k total citations
12 papers, 760 citations indexed

About

Philip M. Tedeschi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Philip M. Tedeschi has authored 12 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Philip M. Tedeschi's work include Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Philip M. Tedeschi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Philip M. Tedeschi collaborates with scholars based in United States, United Kingdom and Indonesia. Philip M. Tedeschi's co-authors include Joseph R. Bertino, Alexei Vázquez, John E. Kerrigan, Kim M. Hirshfield, Sonia Dolfi, Zoltán N. Oltvai, Giuseppe Cilento, Murugesan Gounder, Emine Ercikan Abali and Kathleen W. Scotto and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

In The Last Decade

Philip M. Tedeschi

12 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip M. Tedeschi United States 11 523 309 85 62 52 12 760
Sarah E. LeBoeuf United States 12 1.1k 2.1× 428 1.4× 160 1.9× 59 1.0× 56 1.1× 14 1.4k
Olesya A. Ulanovskaya United States 15 636 1.2× 139 0.4× 134 1.6× 48 0.8× 37 0.7× 18 925
Murugesan Gounder United States 13 629 1.2× 264 0.9× 283 3.3× 41 0.7× 26 0.5× 36 962
Juan I. Garaycoechea United Kingdom 13 969 1.9× 323 1.0× 160 1.9× 53 0.9× 47 0.9× 16 1.4k
Shu Lim United States 16 688 1.3× 344 1.1× 93 1.1× 88 1.4× 88 1.7× 22 1.1k
Jinjun Gao China 14 862 1.6× 332 1.1× 141 1.7× 60 1.0× 83 1.6× 22 1.2k
Beth Pietrak United States 15 660 1.3× 364 1.2× 112 1.3× 59 1.0× 23 0.4× 22 1.1k
Aparajita H. Chourasia United States 8 784 1.5× 299 1.0× 94 1.1× 28 0.5× 9 0.2× 19 1.1k
Thu H. Truong United States 15 743 1.4× 155 0.5× 251 3.0× 154 2.5× 53 1.0× 24 1.2k

Countries citing papers authored by Philip M. Tedeschi

Since Specialization
Citations

This map shows the geographic impact of Philip M. Tedeschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip M. Tedeschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip M. Tedeschi more than expected).

Fields of papers citing papers by Philip M. Tedeschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip M. Tedeschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip M. Tedeschi. The network helps show where Philip M. Tedeschi may publish in the future.

Co-authorship network of co-authors of Philip M. Tedeschi

This figure shows the co-authorship network connecting the top 25 collaborators of Philip M. Tedeschi. A scholar is included among the top collaborators of Philip M. Tedeschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip M. Tedeschi. Philip M. Tedeschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rather, Gulam M., et al.. (2021). In cancer, all roads lead to NADPH. Pharmacology & Therapeutics. 226. 107864–107864. 61 indexed citations
2.
Tedeschi, Philip M., Nitu Bansal, John E. Kerrigan, et al.. (2016). NAD+ Kinase as a Therapeutic Target in Cancer. Clinical Cancer Research. 22(21). 5189–5195. 68 indexed citations
3.
Tedeschi, Philip M., et al.. (2015). Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination. Cancer Chemotherapy and Pharmacology. 75(6). 1247–1252. 2 indexed citations
4.
Tedeschi, Philip M., Hongxia Lin, Murugesan Gounder, et al.. (2015). Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with Chemotherapy. Molecular Pharmacology. 88(4). 720–727. 35 indexed citations
5.
Tedeschi, Philip M., Nadine Johnson-Farley, Hongxia Lin, et al.. (2015). Quantification of folate metabolism using transient metabolic flux analysis. Cancer & Metabolism. 3(1). 6–6. 20 indexed citations
6.
Tedeschi, Philip M., Alexei Vázquez, John E. Kerrigan, & Joseph R. Bertino. (2015). Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development. Molecular Cancer Research. 13(10). 1361–1366. 64 indexed citations
7.
Tedeschi, Philip M., et al.. (2014). Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts. Cancer Chemotherapy and Pharmacology. 74(5). 1029–1032. 13 indexed citations
8.
Dolfi, Sonia, Leo Li‐Ying Chan, Jean Qiu, et al.. (2013). The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer & Metabolism. 1(1). 20–20. 147 indexed citations
9.
Tedeschi, Philip M., Elke Markert, Murugesan Gounder, et al.. (2013). Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death and Disease. 4(10). e877–e877. 207 indexed citations
10.
Tedeschi, Philip M., Debabrata Banerjee, Kathleen W. Scotto, et al.. (2012). Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs. Molecular Pharmacology. 83(2). 339–353. 27 indexed citations
11.
Vázquez, Alexei, Philip M. Tedeschi, & Joseph R. Bertino. (2012). Overexpression of the Mitochondrial Folate and Glycine–Serine Pathway: A New Determinant of Methotrexate Selectivity in Tumors. Cancer Research. 73(2). 478–482. 64 indexed citations
12.
Cilento, Giuseppe & Philip M. Tedeschi. (1961). Pyridine Coenzymes. Journal of Biological Chemistry. 236(3). 907–910. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah E. LeBoeuf Breakdown of academic impact, for papers by Olesya A. Ulanovskaya Breakdown of academic impact, for papers by Murugesan Gounder Breakdown of academic impact, for papers by Juan I. Garaycoechea Breakdown of academic impact, for papers by Shu Lim Breakdown of academic impact, for papers by Jinjun Gao Breakdown of academic impact, for papers by Beth Pietrak Breakdown of academic impact, for papers by Aparajita H. Chourasia Breakdown of academic impact, for papers by Thu H. Truong
Rankless by CCL
2026